Quantcast
Tag archive for ‘Gilead Sciences’
By The Dispatch On Wednesday, July 23rd, 2014
1 Comment

Gilead Sciences cancer drug, Zydelig, receives FDA approval

The U.S. Food and Drug Administration today approved Zydelig (idelalisib) to treat patients with three types of blood cancers. Zydelig is being granted traditional approval to treat patients whose chronic lymphocytic More...

By The Dispatch On Wednesday, July 16th, 2014
0 Comments

Senators question Gilead Sciences CEO about pricey Hepatitis C drug, Sovaldi

Senate Finance Committee Chairman Ron Wyden, D-Ore., and senior Finance Committee member Chuck Grassley, R-Iowa, Friday requested detailed pricing information on a costly new Hepatitis C virus (HCV) drug. Wyden More...


Recent Posts

April 11, 2021, Comments Off on

April 11, 2021, Comments Off on

April 10, 2021, Comments Off on

April 10, 2021, Comments Off on

April 7, 2021, Comments Off on

April 7, 2021, Comments Off on

April 7, 2021, Comments Off on

DISPATCH BLOGS

Splash Page logo 300x146 Today in History